| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $43.1K | +1.65K | +0.25% | $26.10 | 671K | Dec 7, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$242K | -1.65K | -0.25% | $146.54 | 669K | Dec 7, 2021 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $319K | +12.2K | +1.83% | $26.10 | 681K | Dec 7, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.81M | -12.2K | -1.8% | $147.83 | 669K | Dec 7, 2021 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $383K | +14.7K | +2.2% | $26.10 | 684K | Dec 7, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$2.18M | -14.7K | -2.15% | $148.27 | 669K | Dec 7, 2021 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $301K | +11.5K | +1.72% | $26.10 | 681K | Dec 7, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.72M | -11.5K | -1.69% | $149.56 | 669K | Dec 7, 2021 | Direct | F1, F2, F6 |
| transaction | SGEN | Common Stock | Options Exercise | $140K | +5.35K | +0.8% | $26.10 | 675K | Dec 7, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$804K | -5.35K | -0.79% | $150.38 | 669K | Dec 7, 2021 | Direct | F1, F2, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.65K | -0.91% | $0.00 | 180K | Dec 7, 2021 | Common Stock | 1.65K | $26.10 | Direct | F8 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -12.2K | -6.79% | $0.00 | 168K | Dec 7, 2021 | Common Stock | 12.2K | $26.10 | Direct | F8 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -14.7K | -8.75% | $0.00 | 153K | Dec 7, 2021 | Common Stock | 14.7K | $26.10 | Direct | F8 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -11.5K | -7.52% | $0.00 | 142K | Dec 7, 2021 | Common Stock | 11.5K | $26.10 | Direct | F8 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -5.35K | -3.77% | $0.00 | 136K | Dec 7, 2021 | Common Stock | 5.35K | $26.10 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $146.02 to $146.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $147.09 to $148.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $148.09 to $149.07. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $149.10 to $150.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Reflects sales of common stock executed in multiple transactions at prices ranging from $150.10 to $151.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F8 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |